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therapy which treats diseases by puncturing acupointsand
meridians with various needling instruments. Data analysis
was performed through RevMan 5.3 software and effect esti-
mate was shown as relative risk (RR) or mean difference (MD)
with a 95% conﬁdence interval (CI).
Results: We got 60 trials which involved 4254 partici-
pants. These included RCTs were of poor methodological
quality. Six types of acupuncture therapies were identi-
ﬁed, including manual acupuncture, electro-acupuncture,
needle knocking acupuncture, warm-needling and moxibus-
tion, scalp acupuncture and mao-acupuncture. Meta-analysis
showed that manual acupuncture had better effect on global
symptom improvement compared with mecobalamin (RR:
1.30; 95%CI: 1.18 to 1.43), Vitamin B (RR: 1.56; 95%CI: 1.30
to 1.87), and no treatment (RR: 1.97; 95%CI: 1.15 to 3.38).
Manual acupuncture combined with mecobalamin had bet-
ter effect on global symptom improvement thanmecobalamin
alone (RR: 1.80; 95%CI: 1.32 to 2.47). Electro-acupuncture
had better effect on global symptom improvement than
mecobalamin (RR: 1.26; 95%CI: 1.15 to 1.40) and Vitamin B
(RR: 2.07; 95%CI: 1.40 to 3.05). Needle knocking acupunc-
ture combined with mecobalamin had better effect on global
symptom improvement than mecobalamin alone (RR: 1.36;
95%CI: 0.87 to 2.11). Only 9 articles reported the adverse
events.
Conclusion: Because of the high risk of bias and the poten-
tial publication bias of these trials of acupuncture therapy
for DPN, we cannot draw conﬁrmative clinical conclusion.
Future researches need rigorously instituted, clearly deﬁned
and internationally recognized outcome measures.
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Purpose:This review is to systematically evaluate the effec-
tiveness and safety of Chinese herbal medicine (CHM) plus
nucleotide analogues (NAs) for treating compensated HBV-
related cirrhosis.
Methods: We mainly searched six databases from their
inception to October 9, 2014. The search terms were “cir-
rhosis”, “hepatitis B”, “compensat*”, “traditional Chinese
medicine” and “herbal medicine” in English or Chinese.
We included randomized controlled trials (RCTs) and quasi-
RCTs. Trials involving HBV-related compensated participants
receivedNAs andNAs plus CHMwere included. The liver ﬁbro-
sis biomarkers (LFsB) were the primary outcomes and the
liver function biomarkers (LFcB), liver stiffness (LS), quality
of life (QL) and adverse events were the secondary outcomes.
According to the Cochrane risk of bias criteria, we assessed
the methodological quality of the included trials. According to
the CHM, we did subgroup analyses. We would do sensitivity
analyses when outlier results were found.
Results: 45trials including 3497 participants were included.
The quality of most of the trials was moderate and low. Three
comparisons were included. The level of HA, LN, PCIII,IV-C,
ALT, AST, TBiL could be reduced in all the comparisons. How-
ever, for ALB, two comparisons (CHM plus LAM versus LAM
and CHM plus ETV versus ETV) showed the combined treat-
ment could improve the level of ALB. The comparison of CHM
plus ADV versus ADV suggested no signiﬁcant difference in
improving it (pooled MD-0.32; 95% CI [-1.20, 0.57]; P<0.00001;
I2=91%). For the level of LS, the combined treatment was bet-
ter in decreasing it. No trial evaluated QL and reported severe
adverse events.
Conclusion: CHM plus NAs might have potential advan-
tages in improving LFsB, LFcB and LS. However, considering
the quality of the trials included, the conclusion should
be given with caution and more standardized RCTs were
needed.(Supported by the 973 Program of 2011CB505105.).
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Purpose: This study aims to analyze the co-occurrence of
pathological symptoms and corresponding acupoints as docu-
mented by the comprehensive acupuncture and moxibustion
records in the classical texts of Far East traditionalmedicine as
an aid to a more efﬁcient understanding of the tacit treatment
principles of ancient physicians.
Methods: The Classic of Supporting Life with Acupunc-
ture and Moxibustion (Zhenjiu Zisheng Jing; hereinafter ZZJ),
which contains the largest amount of treatment cases and
left a strong impact on the Far East medical history, was
selected as the primary reference book for the analysis.
ZZJ was ﬁrst digitized and co-occurring pathology-acupoint
pairs were extracted and preprocessed into an analyzable
format. The pathology-acupoint co-occurrence analysis was
performed by applying 5 values of set-theoretic measures
(weighted Euclidean distance, Canberra distance, Euclidean
distance, chi-squared distance, and Jaccard similarity), which
measure the distance between the observed and expected
co-occurrence counts, and 2 values of probabilistic measures
(association strength and Fisher’s exact test), which mea-
sure the probability of observed co-occurrences. The analysis
results were used for a prediction simulation in order to mea-
sure and compare the extent to which pathologies can be
predicted from acupoints.
Results: The treatment records contained in ZZJ were
preprocessed, which yielded 4162 pathology-acupoint sets.
Co-occurrence was performed applying 7 different analysis
variables, followed by a prediction simulation. The prediction
simulation results revealed the weighted Euclidean distance
